LVH and Wistar Institute to Study Cancer
Lehigh Valley Hospital and The Wistar Institute will form a research partnership to study cancer.
Lehigh Valley Health Network and The Wistar Institute in Philadelphia will collaborate on cancer research, officials announced Tuesday.
“This affiliation is an important step in our ongoing efforts here at Lehigh Valley Health Network to bring more hope and more options to people in the Lehigh Valley faced with cancer,” Ronald Swinfard, MD, LVHN’s president and CEO, said in a news release.
The Wistar Institute, established in 1972, has been on the forefront of biomedical research, including the identification of genes associated with cancer.
LVH surgeons will provide tissue samples from patients' tumors for scientists to study ways to target an individual's genetic predisposition to cancer, according to a report in the Morning Call.
“Through this clinical research in partnership with Wistar, our physicians and patients will have the opportunity to help find future cures by assisting the scientists at the forefront of scientific discovery,” Swinfard said.
Swinfard and Dario Altieri, MD, chief scientific officer and director of The Wistar Institute Cancer Center, made the announcement at the Cancer Center of Lehigh Valley Hospital-Cedar Crest.
The two institutions are already working together on research into resistance to therapy in advanced melanoma. “Resistance to therapy invariably builds, to the frustration of patients and melanoma specialists,” Dr. Suresh Nair, medical oncologist at LVHN, said in a news release.
A second project is being planned to study how genetic differences affect immune response against ovarian cancer. Future studies are planned for brain tumors and pancreatic and lung cancer.
In February 2011, LVHN announced a partnership with the Moffitt Cancer Center and Research Institute of Tampa, Fla., to enable cancer patients to participate in advanced clinical research trials.